Choueiry, F.; Singh, S.; Sircar, A.; Laliotis, G.; Sun, X.; Chavdoula, E.; Zhang, S.; Helmig-Mason, J.; Hart, A.; Epperla, N.;
et al. Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma. Cancers 2021, 13, 2146.
https://doi.org/10.3390/cancers13092146
AMA Style
Choueiry F, Singh S, Sircar A, Laliotis G, Sun X, Chavdoula E, Zhang S, Helmig-Mason J, Hart A, Epperla N,
et al. Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma. Cancers. 2021; 13(9):2146.
https://doi.org/10.3390/cancers13092146
Chicago/Turabian Style
Choueiry, Fouad, Satishkumar Singh, Anuvrat Sircar, Georgios Laliotis, Xiaowei Sun, Evangelia Chavdoula, Shiqi Zhang, JoBeth Helmig-Mason, Amber Hart, Narendranath Epperla,
and et al. 2021. "Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma" Cancers 13, no. 9: 2146.
https://doi.org/10.3390/cancers13092146
APA Style
Choueiry, F., Singh, S., Sircar, A., Laliotis, G., Sun, X., Chavdoula, E., Zhang, S., Helmig-Mason, J., Hart, A., Epperla, N., Tsichlis, P., Baiocchi, R., Alinari, L., Zhu, J., & Sehgal, L.
(2021). Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma. Cancers, 13(9), 2146.
https://doi.org/10.3390/cancers13092146